This trial is testing whether the drug Dexmedetomidine can prevent postoperative cognitive dysfunction (POCD), which is when patients have trouble thinking and remembering after surgery.
1 Primary · 10 Secondary · Reporting Duration: 3, 6, 12 months
Active Control
2400 Total Participants · 2 Treatment Groups
Primary Treatment: Dexmedetomidine Hydrochloride Group · No Placebo Group · Phase 4
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: